NASDAQ · Shell Companies
Aimei Health Technology Co., Ltd - Right (AFJKR) Stock
$0.09
-5.16%
NASDAQ: AFJKR
Financial Services
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Update: Aimei Health Technology Shares Fall After Terminating Merger Deal With United Hydrogen
MT Newswires · Jul 9, 2026
Top Midday Decliners
MT Newswires · Jul 9, 2026
Top Premarket Decliners
MT Newswires · Jul 9, 2026
Aimei Health Terminates Merger Deal With United Hydrogen Group; Shares Drop Pre-Bell
MT Newswires · Jul 9, 2026
AIMEI HEALTH TECHNOLOGY CO., LTD. ANNOUNCES TERMINATION OF BUSINESS COMBINATION AGREEMENT WITH UNITED HYDROGEN GROUP INC.
GlobeNewswire · Jul 8, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Peer Comparison
About Aimei Health Technology Co., Ltd - Right
Aimei Health Technology Co., Ltd - Right is led by CEO Junheng Xie, employs 2 people, headquartered in US, publicly traded since 2023.
Aimei Health Technology Co., Ltd - Right (AFJKR) stock trades at $0.09 with a market capitalization of $633874. The stock is valued at a price-to-earnings (P/E) ratio of 177.57, price-to-book of 1.57, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.07 and $0.49, and currently trades 81.6% below its 52-week high.
On profitability, Aimei Health Technology Co., Ltd - Right generates a return on equity (ROE) of 2.49%, return on capital employed of -7.31%, an operating margin of 0.00%, a net profit margin of 0.00%.